Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

Hollis-Eden Pharmaceuticals Inc. (HEPH)

()

News & PR
Market Currents

Buzz
Twitter: HEPH

Business Intelligence
Transcripts
Events
Key Developments


	52wk high:
	52wk low:
	EPS:
	PE:
	Dividend:
	Yield:
	Market Cap:
	Exchange:

Analysis - Latest Articles

Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division

Centient Biotech Investor • Mar 30 • 1 Comment
Biotech In Review: Adams Respiratory Guides Lower

Centient Biotech Investor • Mar 18 • Comment!
Hollis-Eden: BioDefense Drug Neumune's Failure Sickens Shareholders

10Q Detective • Mar 14 • 1 Comment
Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune

Centient Biotech Investor • Mar 09 • Comment!
Hollis-Eden: Government Contract Cancellation Could Mean Reorganization

Andrew Vaino • Mar 08 • Comment!
Hollis-Eden: Stock Volatility Coming Up

Andrew Vaino • Mar 05 • Comment!

More articles on HEPH »

Instablogs

Speculative BioTechs: Finding the Next 10-Bagger

Thu May 7, 2009 • Joe Kunkle • 5 Comments
Hollis Eden Pharmaceuticals-A Saga of Ego and Mismanagement

Wed April 8, 2009 • Craig Miller/Metrobank's Views • Comment!

Write a post on HEPH | More Instablogs on HEPH »

Sentiment

What advice would you give to
HEPH?

What's your view of HEPH?

Make sure you include HEPH